临床外科杂志 ›› 2022, Vol. 30 ›› Issue (11): 1094-1097.doi: 10.3969/j.issn.1005-6483.2022.11.028

• 综述与讲座 • 上一篇    下一篇

胆管癌光动力治疗的基础与临床研究新进展

  

  1. 572022 中国人民解放军总医院海南医院肝胆外科(刘淞淞、卢鹏),激光医学中心(谭一舟)
  • 收稿日期:2022-10-10 接受日期:2022-10-10 出版日期:2022-11-20 发布日期:2022-11-20
  • 通讯作者: 通信作者:卢鹏,Email:lupeng301@126.com

New progress in basic and clinical research of photodynamic therapy for cholangiocarcinoma

  1. Department of Hepatobiliary Surgery,Hainan Hospital,Chinese People's Liberation Army (PLA) General Hospital,Hainan 572022 China
  • Received:2022-10-10 Accepted:2022-10-10 Online:2022-11-20 Published:2022-11-20

摘要: 胆管癌起病隐匿且恶性程度极高,大多数病人初诊时已是晚期,失去了根治性手术的机会,不可切除的胆管癌病人生存期极短且生存质量较低。目前对于不可切除的胆管癌的常见治疗方法有胆道支架、放化疗、射频消融、靶向和免疫治疗等,但由于胆道肿瘤恶性程度高,放化疗不敏感且易发生耐药,现有治疗手段对病人生存时间和生存质量的提升亦有限。因此,临床医生亟需探索新的治疗策略以突破当下的困境。光动力疗法作为一种治疗胆管癌的新手段,以其优异的局部抗肿瘤效果引起广泛关注。本文主要针对近年来光敏剂的研制和发展、光动力治疗(PDT)的分子作用机制、PDT的临床应用等相关情况进行归纳总结,结合我们团队开展的相应临床工作,阐述PDT研究的热点和潜力,为临床及科研提供参考。

关键词: 胆管癌, 光动力治疗, 光敏剂

Abstract: The onset of cholangiocarcinoma is insidious and the degree of malignancy is extremely high.Most of the patients are already in the advanced stage when they are first diagnosed and have lost the opportunity of radical surgery.The prognosis of patients is poor and the quality of life is low.Currently,the common treatment methods for unresectable cholangiocarcinoma include biliary stent,radiotherapy and chemotherapy,radiofrequency ablation,targeted therapy and immunotherapy,etc.However,due to the poor degree of malignancy of biliary duct tumor,radiotherapy and chemotherapy are not sensitive and prone to drug resistance,the existing treatment methods are limited in improving the survival time and quality of life of patients.Therefore,clinicians urgently need to explore new treatment strategies to overcome the current dilemma.Photodynamic therapy (PDT),as a new treatment for cholangiocarcinoma,has attracted attention due to its excellent local anti-tumor effect.In this paper,the research and development of photosensitizers,the molecular mechanism,and the clinical application of PDT in recent years are summarized.Combined with the corresponding clinical work carried out by the author's team,the spots and potential of PDT research are described,so as to provide references for clinical and scientific research.

Key words: cholangiocarcinoma, photodynamic therapy, photosensitizers

[1] 王达 陈勇军. 全尾叶切除对于肝门部胆管癌根治术的价值[J]. 临床外科杂志, 2022, 30(11): 1012-1015.
[2] 蔡秀军 陈鸣宇 曹佳胜. 美国国家综合癌症网络肝胆肿瘤临床实践指南2020版更新解读(胆管癌部分)[J]. 临床外科杂志, 2021, 29(1): 7-9.
[3] 刘超. 日本名古屋大学肝门部胆管癌外科治疗策略[J]. 临床外科杂志, 2020, 28(8): 704-706.
[4] 于小鹏 童焕军 汤朝晖. 术前影像学检查联合临床实验室指标在肝内胆管癌术前诊断分型中价值的探讨[J]. 临床外科杂志, 2020, 28(8): 707-710.
[5] 陈勇军. 腹腔镜肝门部胆管癌根治术的现状和争议[J]. 临床外科杂志, 2020, 28(8): 719-721.
[6] 彭丰 王敏 谢昱 秦仁义. 长链非编码RNA SNHG1在胆管癌中的表达与临床特征及预后的相关性分析[J]. 临床外科杂志, 2020, 28(8): 725-727.
[7] 王葵, 陈秦俊杰, 夏勇, 李俊, 阎振林, 沈锋. 肝内胆管癌的外科综合治疗[J]. 临床外科杂志, 2019, 27(8): 638-641.
[8] 林有智 陈孝平 陆玉蕾等. Smad4在TGF-β诱导人胆管癌细胞上皮间质转化中的作用 [J]. 临床外科杂志, 2013, 21(5): 340-342.
[9] 程玉 罗云藩 廖锦岐等. 肝内胆管结石合并胆管癌38例临床分析[J]. 临床外科杂志, 2012, 20(7): 473-475.
[10] 李艳兵 朱红霞 满泉 庞慧芳 吕兴 严斌. 联合肝叶切除治疗肝门部胆管癌[J]. 临床外科杂志, 2011, 19(12): 835-835.
[11] 陈汝福. 肝门部胆管癌诊治进展[J]. 临床外科杂志, 2011, 19(11): 739-739.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!